Increasing pacemaker lead impedance and pacing threshold after initiation of chemotherapy with doxorubicin and cyclophosphamide

HeartRhythm Case Rep. 2022 Sep 24;8(12):845-848. doi: 10.1016/j.hrcr.2022.09.011. eCollection 2022 Dec.
No abstract available

Keywords: Cardio-oncology; Cardiotoxicity; Chemotherapy; Cyclophosphamide; Doxorubicin; Pacemaker malfunction.

Publication types

  • Case Reports